Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Erythrocyte Complement Receptor 1 and Alzheimer Disease

This study has been completed.
Information provided by (Responsible Party):
CHU de Reims Identifier:
First received: March 26, 2012
Last updated: June 8, 2016
Last verified: March 2012
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: April 2015
  Estimated Primary Completion Date: No date given